

AV-951 is an potent and selective orally bioavailable isoxazole inhibitor of VEGFR1, 2, and 3, kinases at 0.21, 0.16, and 0.24 nM, respectively. Additionally it has nanomolar activity for cKIT and PDGFR at 1.63 and 1.72 nM, respectively. [1] In vitro, AV-951 blocks MAP kinase activation and suppresses the proliferation and migration of endothelial cells. In vivo, it suppresses angiogenesis and tumor progression in human xenografts. [2]AV-951 has been widely studied in clinical trials for the treatment of advanced renal cell carcinoma (RCC) and non-small cell lung cancers (NSCLC). More recent studies are exploring combination therapies with paclitaxel and bevacizumab for breast and colorectal cancer, respectively.
Technical information:
Chemical Formula: | C22H19ClN4O5 | |
CAS #: | 475108-18-0 | |
Molecular Weight: | 454.86 | |
Purity: | > 98% | |
Appearance: | Off White | |
Chemical Name: | 1-(2-chloro-4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-3-(5-methylisoxazol-3-yl)urea | |
Solubility: | Up to 100 mM in DMSO | |
Synonyms: | AV-951, AV 951, AV951, Tivozanib |
Shipping Condition: The product is shipped in a glass vial at ambient temperature.Storage condition: For longer shelf life, store solid powder at 4oC desiccated, or store DMSO solution at -20oC.
Reference:
1. | Eskens et al., Biologic and clinical activity of tivozanib (AV-951, KRN-951), a selective inhibitor of VEGF receptor-1, -2, and -3 tyrosine kinases, in a 4-week-on, 2-week-off schedule in patients with advanced solid tumors. Clin Cancer Res 2011, 17, 7156-7163 Pubmed ID:21976547 |
2. | Campas et al., Tivozanib. Drugs Fut 2009, 34 (10), 793 Pubmed ID:ISSN: 0377-8282 |
Other Information:
Product Specification (pdf) MSDS (pdf) Certificate of Analysis is available upon request.
Cellagen的ChamQ SYBR qPCR预混液(无ROX)| Q321产品描述ChamQSYBR®qPCR预混液(Vazyme,#Q321)由香槟Taq DNA聚合酶(Vazyme,#P122)通过抗体修饰的热启动激活技术保护,是专为基于SYBR Green I的定量PCR(qPCR)设计的。ChamQSYBR®qPCR Master Mix的优化缓冲液系统中的独特因素(即促进特异性的Exactor)大大提高了其灵敏度和特异性。该混合物以2倍反应浓度制备,可直接用于鲁棒性低模板qPCR,具有高灵敏度,特异性和可靠性。优点特异性+敏感性的最佳组合。独特的抗体修饰的热启动taq,具有独特的特异性促进因子。Mg2 +和染料的最佳浓度。